Evergreen Theragnostics, Inc.

About Evergreen Theragnostics, Inc.

Evergreen Theragnostics aims to improve options for cancer patients through the development and use of theragnostic radiopharmaceuticals.

Products & Services

CDMO Services:Contract Development and Manufacturing Organization services for radiopharmaceuticals.

Products & Pipeline:Development of radiopharmaceutical products for diagnostic and therapeutic purposes.

Specialties

Theragnostic Radiopharmaceuticals Cancer Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Capital Raise T: - FT: Capital Raise	A: 26000000 MR: - FA: $26M FAN: 26000000	D: 2024-04-16 FD: 2024-04-16	2 investors
2	RT: Series B T: - FT: Series B	A: 15000000 MR: - FA: $15M FAN: 15000000	D: 2023-03-13 FD: 2023-03-13	1 investors

Capital Raise Latest

2024-04-16

$26.0M

2 investors (Pro only)

Series B 2023-03-13

$15.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Dipesh Patel

GENERAL COUNSEL

T

Tom Reiner

CHIEF SCIENTIFIC OFFICER

A

Alison Tillbrook

VP of Human Resources

Recent News